Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children

NCT00076999 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: TPV oral solution
DRUG: TPV oral solution
DRUG: RTV oral solution
DRUG: RTV oral solution

Sponsor

Boehringer Ingelheim